Form D · Other Health Care
Massive Bio, Inc.
New York, NY · CIK 0001775507
Offering snapshot reported May 2, 2019 · SEC filing
- Reported sold
- $2.53M Offering amount: $5.53M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $500K Reported outside-investor minimum
- First sale
- Apr 10, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 2, 2019 | Initial | $2,529,699 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-338702
Source: Form D, filed May 2, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Selin Kurnaz | Executive |
| Arturo Loaiza Bonilla | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
90 West St. Apt 12 M
New York, NY, 10006
New York, NY, 10006